Cancer Research and Treatment

Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies

International Journal of Gynecology & Obstetrics.2024; 164(2): 436. CrossRef

Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?

Jonadab E Olguin, Monica G Mendoza-Rodriguez, C Angel Sanchez-Barrera, Luis I Terrazas

World Journal of Gastrointestinal Oncology.2023; 15(2): 251. CrossRef

Systemic treatment for metastatic colorectal cancer

Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana

World Journal of Gastroenterology.2023; 29(10): 1425. CrossRef

Systemic treatment for metastatic colorectal cancer

Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana

World Journal of Gastroenterology.2023; 29(10): 1569. CrossRef

Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability

Julien Taïeb, Olivier Bouche, Thierry André, Karine Le Malicot, Pierre Laurent-Puig, Jérémie Bez, Clémence Toullec, Christophe Borg, Violaine Randrian, Ludovic Evesque, Stéphane Corbinais, Hervé Perrier, Bruno Buecher, Frederic Di Fiore, Claire Gallois, J

Circulating Tumor DNA Response and Minimal Residual Disease Assessment in DNA Polymerase Epsilon-Mutated Colorectal Cancer Undergoing Immunotherapy

Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold?

Hassan Abushukair, Obada Ababneh, Ayah Al-Bzour, Ibrahim Halil Sahin, Anwaar Saeed

Expert Review of Molecular Diagnostics.2023; 23(10): 863. CrossRef

Immunological Assessment of Recent Immunotherapy for Colorectal Cancer

Immunological Investigations.2023; 52(8): 1065. CrossRef

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

Daniele Fanale, Lidia Rita Corsini, Raimondo Scalia, Chiara Brando, Alessandra Cucinella, Giorgio Madonia, Alessandra Dimino, Clarissa Filorizzo, Nadia Barraco, Marco Bono, Alessia Fiorino, Luigi Magrin, Roberta Sciacchitano, Alessandro Perez, Tancredi Di

Critical Reviews in Oncology/Hematology.2022; 170: 103597. CrossRef

Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade

Alecsandra Gorzo, Diana Galos, Simona Ruxandra Volovat, Cristian Virgil Lungulescu, Claudia Burz, Daniel Sur

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient

Yang Fu, Yue Zheng, Pei-Pei Wang, Yue-Yun Chen, Zhen-Yu Ding

CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors

Inken Salewski, Julia Henne, Leonie Engster, Paula Krone, Bjoern Schneider, Caterina Redwanz, Heiko Lemcke, Larissa Henze, Christian Junghanss, Claudia Maletzki

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume

Younes Belkouchi, Laetitia Nebot-Bral, Littisha Lawrance, Michele Kind, Clémence David, Samy Ammari, Paul-Henry Cournède, Hugues Talbot, Perrine Vuagnat, Cristina Smolenschi, Patricia L. Kannouche, Nathalie Chaput, Nathalie Lassau, Antoine Hollebecque

Predictive biomarkers of colon cancer immunotherapy: Present and future

Research Progress in the Treatment of Liver Metastasis from Colon Cancer

Advances in Clinical Medicine.2022; 12(12): 11179. CrossRef

Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers

Kyusang Hwang, Jin Hwan Yoon, Ji Hyun Lee, Sukmook Lee

Complete Response to Pembrolizumab in Advanced Colon Cancer Harboring Somatic POLE F367S Mutation with Microsatellite Stability Status: A Case Study

OncoTargets and Therapy.2021; Volume 14: 1791. CrossRef

Comprehensive tumor molecular profile analysis in clinical practice

Mustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, Aikaterini Tsantikidi, Vasiliki-Metaxa Mariatou, Georgios Tsaousis, Evgenia Kapeni, Evgenia Bourkoula, Dimitrios Fotiou, Georgios Kapetsis, Ioannis Boukovinas, Nikolaos Touroutoglou, Athanasios Fassa

Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors

Inken Salewski, Steffen Kuntoff, Andreas Kuemmel, Rico Feldtmann, Stephan B. Felix, Larissa Henze, Christian Junghanss, Claudia Maletzki

Cancer Immunology, Immunotherapy.2021; 70(12): 3405. CrossRef

Immune Checkpoint Inhibitor Associated Hepatotoxicity in Primary Liver Cancer Versus Other Cancers: A Systematic Review and Meta‐Analysis

Jianyang Fu, Wang-Zhong Li, Nicole A. McGrath, Chunwei Walter Lai, Gagandeep Brar, Yan-Qun Xiang, Changqing Xie

Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives

Xuezhen Zeng, Simon E. Ward, Jingying Zhou, Alfred S. L. Cheng

Perspectives on Immunotherapy of Metastatic Colorectal Cancer

Yongjiu Dai, Wenhu Zhao, Lei Yue, Xinzheng Dai, Dawei Rong, Fan Wu, Jian Gu, Xiaofeng Qian

Treatment Efficacy of Immune Checkpoint Inhibitors for Patients with Advanced or Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine.2021; 10(16): 3599. CrossRef

Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes

Dmitrii Shek, Liia Akhuba, Matteo S. Carlino, Adnan Nagrial, Tania Moujaber, Scott A. Read, Bo Gao, Golo Ahlenstiel

Efficacy of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer: Analysis of Three Phase-II Trials

Luca Cancanelli, Melania Rivano, Lorenzo Di Spazio, Marco Chiumente, Daniele Mengato, Andrea Messori

Molecular Targets for the Treatment of Metastatic Colorectal Cancer

Romain Cohen, Thomas Pudlarz, Jean-François Delattre, Raphaël Colle, Thierry André

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study

Romain Cohen, Jaafar Bennouna, Aurélia Meurisse, Christophe Tournigand, Christelle De La Fouchardière, David Tougeron, Christophe Borg, Thibault Mazard, Benoist Chibaudel, Marie-Line Garcia-Larnicol, Magali Svrcek, Dewi Vernerey, Yves Menu, Thierry André

Journal for ImmunoTherapy of Cancer.2020; 8(2): e001499. CrossRef

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis

Xianzhe Yu, Lingling Zhu, Jiewei Liu, Ming Xie, Jiang Chen, Jianguo Li

OncoTargets and Therapy.2020; Volume 13: 11645. CrossRef

Current status and perspectives of immune checkpoint inhibitors for colorectal cancer

Hidekazu Hirano, Atsuo Takashima, Tetsuya Hamaguchi, Dai Shida, Yukihide Kanemitsu

Japanese Journal of Clinical Oncology.2020;[Epub] CrossRef